RE:Care sales From the News release of Aug 16, 2021: TORONTO, ON / ACCESSWIRE / August 16, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), a healthcare company working to reduce the risk of cancer and other chronic diseases through early detection and intervention, today announced the signing of a share purchase agreement (the "Definitive Agreement") to acquire all of the shares of Clinics Operations Limited, a provider of specialist clinical services across Europe and North America, and wholly owned subsidiary of Health Clinics Limited (the "Acquisition").
Transaction Highlights
- Adds ~$4 million in annual revenue and is immediately accretive to StageZero
- Provides StageZero Life Sciences with full access to Care Oncology's network of oncologists and physicians across the United States, including Care Oncology's Los Angeles clinic, and the physicians' healthcare affiliations.
- Positions StageZero to take full advantage of the multi-billion dollar emerging global market for liquid biopsy diagnostic tools and the strong trend toward telehealth and early-disease diagnostics
- Adds experienced management expertise to build out StageZero's clinical offerings and significantly expands the sales and marketing effort.
- Offers synergistic cross-selling opportunities as StageZero provides diagnostic tests to the thousands of current Care Oncology patients, with StageZero liquid diagnostic customers now having access to the full Care Oncology "Patient Journey". This, in turn, provides multiple revenue streams.
From the News release of Sept 2, 2021: TORONTO, ON / ACCESSWIRE / September 2, 2021 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), a healthcare company working to reduce the risk of cancer and other chronic diseases through early detection and intervention, today announced that it has completed its previously announced acquisition of the business of Health Clinics Limited (the "Acquisition"). The Acquisition was completed through the acquisition of all of the shares of Clinics Operations Limited, a provider of specialist clinical services across Europe and North America, and a wholly-owned subsidiary of Health Clinics Limited, and the acquisition of substantially all of the assets of Health Clinics USA, Corp. ("HC USA"), a company in which Health Clinics Limited holds significant ownership interest. From the Interim Financials of Nov 15, 2021 posted on Sedar. Page 31: Revenue for three month ending Sept 30, 2021:
Clinical Consultation $273,398 Deferred Revenue for three month ending Sept 30, 2021:
Clinical Consultation $115,982 Total of $389,380. The acquistion was finalized on Sept 2, 2021, Q3 is July-Sept so this would represent only 1 month of revenue for Clinical Consultation. There was no revenue amount listed under Clinical Consultation prior to Q3, 2021.
brad129 wrote: Where did we get the numbers for Care that prior to acquisition they were doing 1 million per quarter? If correct than we should see minimum 1 million on the books since we have had a full quarter of sales.